Come up with a name for your new list and we'll add to it:
Visterra was acquired by
Otsuka Holdings on July 11, 2018.
Visterra, formerly Parasol Therapeutics, is a biotechnology company that uses its Hierotope Platform to identify unique disease targets and design effective therapeutics. The company's technology is p…